Benjamin Looker - 18 Jan 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
General Counsel
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
18 Jan 2023
Net transactions value
-$44,404
Form type
4
Filing time
19 Jan 2023, 15:58:55 UTC
Previous filing
09 Jun 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $44,404 -6,347 -9% $7.00 64,453 18 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.